Pfizer CEO: Omicron Vaccine Is Coming in March | Amanpour and Company

Pfizer CEO: Omicron Vaccine Is Coming in March | Amanpour and Company

Pfizer CEO Bourla: Omicron-specific Covid vaccine will be ready by MarchПодробнее

Pfizer CEO Bourla: Omicron-specific Covid vaccine will be ready by March

Omicron Vaccine To Be Ready In March, Pfizer CEO SaysПодробнее

Omicron Vaccine To Be Ready In March, Pfizer CEO Says

Pfizer CEO: New COVID-19 vaccine that covers Omicron ‘will be ready in March'Подробнее

Pfizer CEO: New COVID-19 vaccine that covers Omicron ‘will be ready in March'

Pfizer Vaccine Can Work Against Omicron Variant, CEO SaysПодробнее

Pfizer Vaccine Can Work Against Omicron Variant, CEO Says

Walter Isaacson's Experience in the Pfizer Vaccine Trial | Amanpour and CompanyПодробнее

Walter Isaacson's Experience in the Pfizer Vaccine Trial | Amanpour and Company

Pfizer CEO on Omicron Covid-19 Variant, Vaccine SupplyПодробнее

Pfizer CEO on Omicron Covid-19 Variant, Vaccine Supply

Pfizer CEO predicts omicron vaccine will be ready in MarchПодробнее

Pfizer CEO predicts omicron vaccine will be ready in March

Pfizer CEO says Omicron vaccine will be ready in MarchПодробнее

Pfizer CEO says Omicron vaccine will be ready in March

Pfizer CEO expects omicron specific vaccine available by MarchПодробнее

Pfizer CEO expects omicron specific vaccine available by March

Pfizer CEO says fourth COVID vaccine dose may be neededПодробнее

Pfizer CEO says fourth COVID vaccine dose may be needed

Pfizer CEO Albert Bourla talks development of coronavirus vaccine (Full Stream 8/6)Подробнее

Pfizer CEO Albert Bourla talks development of coronavirus vaccine (Full Stream 8/6)

‘If We Need One, We Will Have One:’ Pfizer CEO on Omicron Vaccines and Efficacy | WSJПодробнее

‘If We Need One, We Will Have One:’ Pfizer CEO on Omicron Vaccines and Efficacy | WSJ

Should Vaccination Status Affect Who Gets Emergency Care? | Amanpour and CompanyПодробнее

Should Vaccination Status Affect Who Gets Emergency Care? | Amanpour and Company

Pfizer's CEO on preliminary COVID-19 vaccine dataПодробнее

Pfizer's CEO on preliminary COVID-19 vaccine data

Pfizer CEO sells company’s stock on the day of vaccine newsПодробнее

Pfizer CEO sells company’s stock on the day of vaccine news

Pfizer CEO talks COVID vaccines, vaccine pricing, mRNA technology, and the company’s futureПодробнее

Pfizer CEO talks COVID vaccines, vaccine pricing, mRNA technology, and the company’s future

Pfizer could have a new vaccine against omicron Covid variant in less than 100 days: CEO BourlaПодробнее

Pfizer could have a new vaccine against omicron Covid variant in less than 100 days: CEO Bourla

Pfizer CEO: New Data On Booster Effectiveness Against Omicron Is ‘Very Good News’Подробнее

Pfizer CEO: New Data On Booster Effectiveness Against Omicron Is ‘Very Good News’

When Can We Expect a COVID-19 Vaccine? | Amanpour and CompanyПодробнее

When Can We Expect a COVID-19 Vaccine? | Amanpour and Company